Search clinical trials for: RSV Seropositive

Total 546 results

Duke University

Completed

Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia

Insomnia
University of California, San Francisco

Completed

Intervention for (Those) Recently Informed of Seropositive Status (IRISS) (IRISS)

HIV Infections

United States
University of California, San Francisco

Withdrawn

Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome (RSV)

Insulin Resistance

United States
US Department of Veterans Affairs

Completed

A Multi-Center Study of Reading Rehabilitation in Macular Disease

Retinal Degeneration | Age Related Maculopathy

United States
Ankara University

Completed

Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial) (TurkNICU-RSV)

Respiratory Syncytial Virus Infections | Infections, Epidemics

Turkey
Tokai University
Scientific Committee for Elucidation of Infantile Asthma

Completed

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Recurrent Wheezing | Atopic Asthma
Duke University
National Institute of Nursing Research (NINR)

Completed

Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women

Human Immunodeficiency Virus (HIV) | Self-esteem | Self-efficacy

United States
Massachusetts General Hospital

Completed

Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients

Swallowing Disorder | Aspiration | Long Term Ventilation

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants

Healthy

United States, Australia, Spain, Germany, Canada, Finland, South Africa, Brazil, Israel
University of Witwatersrand, South Africa

Completed

Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women (VICAR2)

Cervical Intraepithelial Neoplasia

South Africa
Fundación Pública Andaluza para la gestión de la...
Hospital Son Espases; Hospital Universitario Virgen Macarena; Hospital Son Llatzer and other collaborators

Completed

Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa (PiperTazo)

Pseudomonas Aeruginosa Infection

Spain
University of Regensburg
Merck Sharp & Dohme LLC

Completed

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Coxarthrosis | Arthroplasties Hip Replacement | Perioperative Blood Loss

Germany
Tel-Aviv Sourasky Medical Center

Unknown

FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma

Acute Bronchiolitis

Israel
Duke University
GlaxoSmithKline

Completed

"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" (FONDA PK)

Renal Insufficiency

United States
MedImmune LLC
AstraZeneca

Completed

An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF (CD-1089)

Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure

United States, Bulgaria, France, Russian Federation, Canada, Sweden, Germany, Italy, Czech Republic
Tel-Aviv Sourasky Medical Center

Unknown

The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.

Influenza | Lower Respiratory Tract Infection | Prematurity | RSV | Upper Respiratory Tract Infection

Israel
Novavax
PATH

Completed

RSV-F Vaccine Dose Ranging Study in Young Women

Respiratory Syncytial Virus (RSV)

United States
Novavax

Completed

RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly

Respiratory Syncytial Virus (RSV)

United States
Pfizer
Emergent Product Development Seattle LLC

Completed

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Active Rheumatoid Arthritis

United States, Canada, Serbia, Japan, Spain, Poland, Hungary, Argentina, Chile, Mexico
Gilead Sciences

Withdrawn

Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus Infections

Australia
MedImmune LLC

Completed

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

Respiratory Syncytial Virus Infections

United States, France, Spain, Denmark, Australia, New Zealand, Israel, United Kingdom, Italy, Sweden, Germany, Hungary, Chile, Argentina, Austria, Brazil, Bulgaria, Canada, Czech Republic, Greece, Iceland, Poland, Russian Federation, ...
Gilead Sciences

Completed

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Johnson & Johnson Medical, China

Terminated

A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

Hepatitis C

China
Gilead Sciences

Completed

A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806

RSV Infection

United States
Duke University

Terminated

A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women

Depression | HIV

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children

Motavizumab Administration for a Second Season for RSV Prophylaxis

Chile, Brazil
GlaxoSmithKline
Sage Analytica

Completed

Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009

Respiratory Syncyctial Virus Vaccines
ADMA Biologics, Inc.

Completed

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

Lower Respiratory Tract Infection | Upper Respiratory Tract Infection

United States, Canada
Quidel Corporation

Completed

Sofia RSV FIA Field Study

Respiratory Syncytial Virus

United States
MedImmune LLC

Completed

Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season

Respiratory Syncytial Virus Infections | Chronic Lung Disease and <= 24 Months of Age or | Premature With Gestational Age <=35 Weeks and <=6 Months of Age

Australia, Chile, New Zealand
University of Washington

Withdrawn

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

HIV Infections | HIV
MedImmune LLC

Completed

An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

Healthy

United States
Oregon Health and Science University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy (CAST)

Diabetic Neuropathy

United States
Abbott

Completed

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection (INSPIRA)

Respiratory Syncytial Virus Infection

Peru
Hvidovre University Hospital

Completed

Study of Vitamin D Supplementation to Male HIV Sero-positive Patients

HIV Seropositive

Denmark
Centers for Disease Control and Prevention

Completed

Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center

HIV Infections | Sexually Transmitted Diseases

United States
Abbott
Assign Data Management and Biostatistics GmbH

Completed

Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA

Premature Infants

Austria
Centers for Disease Control and Prevention

Completed

ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader

HIV Infections

United States
Meir Medical Center

Unknown

Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia

Fibromyalgia

Israel
M.D. Anderson Cancer Center
ICN Pharmaceuticals

Completed

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Hematological Malignancies

United States
MedImmune LLC

Completed

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age (CP149)

Respiratory Syncytial Virus Infections | Respiratory Viral Infections | Parainfluenza Virus 3, Human

United States
MicroDose Therapeutx, Inc

Completed

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

Drug Safety

United States
MicroDose Therapeutx, Inc

Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

Respiratory Syncytial Virus Infections | Drug Safety

United States
MicroDose Therapeutx, Inc

Completed

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers

Drug Safety

United States
Centers for Disease Control and Prevention

Completed

ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques

HIV Infections

United States
Centers for Disease Control and Prevention
Johns Hopkins University; Columbia University; University of Pittsburgh; RTI International and other collaborators

Completed

Housing and Health Study (H&H)

HIV | AIDS
International Vaccine Institute
Siriraj Hospital; Vaccine Technologies Inc.

Completed

Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

Diarrhea | Cholera | Vibrio Infections

Thailand
Novavax

Completed

Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine

Respiratory Syncytial Virus Infections

United States
University of Pittsburgh

Withdrawn

Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women

Bacterial Vaginosis | Herpes Simplex Virus Type II

United States
MedImmune LLC

Completed

A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease

Congenital Heart Disease

United States, Spain, United Kingdom, Canada, Belgium, Germany, Israel, Austria, Poland, Russian Federation, Sweden, Lebanon, France, Czech Republic, Hungary, Denmark, Bulgaria

Search clinical trials for: RSV Seropositive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations